ABOUT DENK

Learn more about DENK PHARMA, our history, our mission and our values.

OUR PRODUCTS

Learn more about our continually growing product portfolio including more than 70 products.

QUALITY

Quality is the guiding principle of all our doing. Learn more about our main focus.

NEWS & MEDIA

Learn more about the latest News on Denk.

In more than 80 countries Denk Pharma employees work on improving health care

Denk Pharma is the winner of the Bavarian Export Prize 2013. The prize is assigned once a year by the Minister of Economy and the Bavarian Chamber of Industry and Commerce to honor bavarian companies, which are successful at foreign commerce.

Learn more about us

We constantly focus on quality – to assure this high product quality throughout the whole lifecycle we count on adequate product packaging

NEWS

expopharm 2017, Booth E-30 (hall 5)

After a successful participation at the expopharm 2016 in Munich, Denk Pharma will also take part at the expopharm 2017 in Dusseldorf for the first time. Use this opportunity and get to know the international product portfolio of Munich`s generic producer at the most important pharmaceutical trade fair in Europe. Visit Denk Pharma´s booth E-30 […]

Expopharm 2016, Munich

12th to 15th of October 2016, Munich, GermanyThis year Denk Pharma participated at the trade fair expopharm in Munich, Germany, with an own booth. Expopharm is the largest pharmaceutical trade fair in Europe and this year more than 26.000 visitors attended. At our booth at the entrance of the international hall we presented our Denk […]

MEDIA

Watch our corporate video and find out more about DENK PHARMA.

WE REGISTER
IN GERMANY

News

Africa Health 2015

Denk Pharma was represented with its own booth at Africa´s leading healthcare exhibition “Africa health” in Johannesburg.

Quality

Our guiding principle

Quality is our guiding principle. Starting with the production process of our products until the product reaches the end consumer.

Products

Clopi-Denk

Our antiplatelet inhibitor of choice. Proven  in mono, dual and triple therapy. Prevention and therapy of atherothrombotic events.